Given the turmoil inside the company, surely it is time for the board to clarify what is happening to the long suffering shareholders. After all we are now deep into January 2019.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025